The present invention is related to antibodies directed to the antigen
PDGFD and uses of such antibodies. In particular, in accordance with the
present invention, there are provided fully human monoclonal antibodies
directed to the antigen PDGFD. Nucelotide sequences encoding, and amino
acid sequences comprising, heavy and light chain immunoglobulin
molecules, particularly sequences corresponding to contiguous heavy and
light chain sequences spanning the framework regions and/or
complementarity determining regions (CDR's), specifically from FR1
through FR4 or CDR1 through CDR3, are provided. Hybridomas or other cell
lines expressing such immunoglobulin molecules and monoclonal antibodies
are also provided.